CircCDK14 ameliorates interleukin-1β-induced chondrocyte damage by the miR-1183/KLF5 pathway in osteoarthritis
The pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA cyclin dependent kinase 14 (circCDK14) in OA development and the underlying mechanism. Human chondrocytes were stimulated by 10 ng/mL interleukin-1β (IL-1...
Saved in:
Published in | Autoimmunity (Chur, Switzerland) Vol. 55; no. 6; pp. 408 - 417 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Taylor & Francis
18.08.2022
Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA cyclin dependent kinase 14 (circCDK14) in OA development and the underlying mechanism.
Human chondrocytes were stimulated by 10 ng/mL interleukin-1β (IL-1β) to mimic OA cell model. The RNA expression of circCDK14, microRNA-1183 (miR-1183) and kruppel like factor 5 (KLF5) was checked through quantitative real-time polymerase chain reaction. Western blot was employed to detect protein expression. Cell viability, proliferation and apoptosis were investigated by cell counting kit-8, 5-Ethynyl-29-deoxyuridine and flow cytometry analysis, respectively. Starbase online database was performed to identify the interaction between miR-1183 and circCDK14 or KLF5. Exosomes were isolated by differential centrifugation and identified by transmission electron microscopy, nanoparticle tracking analysis and western blot analysis.
CircCDK14 and KLF5 expression were significantly decreased, while miR-1183 was increased in OA cartilage tissues and IL-1β-treated chondrocytes in comparison with controls. CircCDK14 overexpression attenuated the inhibitory effect of IL-1β treatment on cell proliferation and the promoting effects on cell apoptosis and extracellular matrix degradation. Additionally, miR-1183 was targeted by circCDK14, and miR-1183 mimics reversed circCDK14-mediated actions in IL-1β-treated chondrocytes. The knockdown of KLF5, a target mRNA of miR-1183, also rescued the effects of miR-1183 inhibitors in IL-1β-induced chondrocytes. Moreover, circCDK14 could induce KLF5 expression by interacting with miR-1183. Further, exosomal circCDK14 had a high diagnostic value in OA.
CircCDK14 reintroduction assuaged IL-1β-caused chondrocyte damage by the miR-1183/KLF5 pathway, providing a diagnostic biomarker for OA. |
---|---|
AbstractList | The pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA cyclin dependent kinase 14 (circCDK14) in OA development and the underlying mechanism.
Human chondrocytes were stimulated by 10 ng/mL interleukin-1β (IL-1β) to mimic OA cell model. The RNA expression of circCDK14, microRNA-1183 (miR-1183) and kruppel like factor 5 (KLF5) was checked through quantitative real-time polymerase chain reaction. Western blot was employed to detect protein expression. Cell viability, proliferation and apoptosis were investigated by cell counting kit-8, 5-Ethynyl-29-deoxyuridine and flow cytometry analysis, respectively. Starbase online database was performed to identify the interaction between miR-1183 and circCDK14 or KLF5. Exosomes were isolated by differential centrifugation and identified by transmission electron microscopy, nanoparticle tracking analysis and western blot analysis.
CircCDK14 and KLF5 expression were significantly decreased, while miR-1183 was increased in OA cartilage tissues and IL-1β-treated chondrocytes in comparison with controls. CircCDK14 overexpression attenuated the inhibitory effect of IL-1β treatment on cell proliferation and the promoting effects on cell apoptosis and extracellular matrix degradation. Additionally, miR-1183 was targeted by circCDK14, and miR-1183 mimics reversed circCDK14-mediated actions in IL-1β-treated chondrocytes. The knockdown of KLF5, a target mRNA of miR-1183, also rescued the effects of miR-1183 inhibitors in IL-1β-induced chondrocytes. Moreover, circCDK14 could induce KLF5 expression by interacting with miR-1183. Further, exosomal circCDK14 had a high diagnostic value in OA.
CircCDK14 reintroduction assuaged IL-1β-caused chondrocyte damage by the miR-1183/KLF5 pathway, providing a diagnostic biomarker for OA. Background The pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA cyclin dependent kinase 14 (circCDK14) in OA development and the underlying mechanism. Methods Human chondrocytes were stimulated by 10 ng/mL interleukin-1β (IL-1β) to mimic OA cell model. The RNA expression of circCDK14, microRNA-1183 (miR-1183) and kruppel like factor 5 (KLF5) was checked through quantitative real-time polymerase chain reaction. Western blot was employed to detect protein expression. Cell viability, proliferation and apoptosis were investigated by cell counting kit-8, 5-Ethynyl-29-deoxyuridine and flow cytometry analysis, respectively. Starbase online database was performed to identify the interaction between miR-1183 and circCDK14 or KLF5. Exosomes were isolated by differential centrifugation and identified by transmission electron microscopy, nanoparticle tracking analysis and western blot analysis. Results CircCDK14 and KLF5 expression were significantly decreased, while miR-1183 was increased in OA cartilage tissues and IL-1β-treated chondrocytes in comparison with controls. CircCDK14 overexpression attenuated the inhibitory effect of IL-1β treatment on cell proliferation and the promoting effects on cell apoptosis and extracellular matrix degradation. Additionally, miR-1183 was targeted by circCDK14, and miR-1183 mimics reversed circCDK14-mediated actions in IL-1β-treated chondrocytes. The knockdown of KLF5, a target mRNA of miR-1183, also rescued the effects of miR-1183 inhibitors in IL-1β-induced chondrocytes. Moreover, circCDK14 could induce KLF5 expression by interacting with miR-1183. Further, exosomal circCDK14 had a high diagnostic value in OA. Conclusion CircCDK14 reintroduction assuaged IL-1β-caused chondrocyte damage by the miR-1183/KLF5 pathway, providing a diagnostic biomarker for OA. The pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA cyclin dependent kinase 14 (circCDK14) in OA development and the underlying mechanism.BACKGROUNDThe pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA cyclin dependent kinase 14 (circCDK14) in OA development and the underlying mechanism.Human chondrocytes were stimulated by 10 ng/mL interleukin-1β (IL-1β) to mimic OA cell model. The RNA expression of circCDK14, microRNA-1183 (miR-1183) and kruppel like factor 5 (KLF5) was checked through quantitative real-time polymerase chain reaction. Western blot was employed to detect protein expression. Cell viability, proliferation and apoptosis were investigated by cell counting kit-8, 5-Ethynyl-29-deoxyuridine and flow cytometry analysis, respectively. Starbase online database was performed to identify the interaction between miR-1183 and circCDK14 or KLF5. Exosomes were isolated by differential centrifugation and identified by transmission electron microscopy, nanoparticle tracking analysis and western blot analysis.METHODSHuman chondrocytes were stimulated by 10 ng/mL interleukin-1β (IL-1β) to mimic OA cell model. The RNA expression of circCDK14, microRNA-1183 (miR-1183) and kruppel like factor 5 (KLF5) was checked through quantitative real-time polymerase chain reaction. Western blot was employed to detect protein expression. Cell viability, proliferation and apoptosis were investigated by cell counting kit-8, 5-Ethynyl-29-deoxyuridine and flow cytometry analysis, respectively. Starbase online database was performed to identify the interaction between miR-1183 and circCDK14 or KLF5. Exosomes were isolated by differential centrifugation and identified by transmission electron microscopy, nanoparticle tracking analysis and western blot analysis.CircCDK14 and KLF5 expression were significantly decreased, while miR-1183 was increased in OA cartilage tissues and IL-1β-treated chondrocytes in comparison with controls. CircCDK14 overexpression attenuated the inhibitory effect of IL-1β treatment on cell proliferation and the promoting effects on cell apoptosis and extracellular matrix degradation. Additionally, miR-1183 was targeted by circCDK14, and miR-1183 mimics reversed circCDK14-mediated actions in IL-1β-treated chondrocytes. The knockdown of KLF5, a target mRNA of miR-1183, also rescued the effects of miR-1183 inhibitors in IL-1β-induced chondrocytes. Moreover, circCDK14 could induce KLF5 expression by interacting with miR-1183. Further, exosomal circCDK14 had a high diagnostic value in OA.RESULTSCircCDK14 and KLF5 expression were significantly decreased, while miR-1183 was increased in OA cartilage tissues and IL-1β-treated chondrocytes in comparison with controls. CircCDK14 overexpression attenuated the inhibitory effect of IL-1β treatment on cell proliferation and the promoting effects on cell apoptosis and extracellular matrix degradation. Additionally, miR-1183 was targeted by circCDK14, and miR-1183 mimics reversed circCDK14-mediated actions in IL-1β-treated chondrocytes. The knockdown of KLF5, a target mRNA of miR-1183, also rescued the effects of miR-1183 inhibitors in IL-1β-induced chondrocytes. Moreover, circCDK14 could induce KLF5 expression by interacting with miR-1183. Further, exosomal circCDK14 had a high diagnostic value in OA.CircCDK14 reintroduction assuaged IL-1β-caused chondrocyte damage by the miR-1183/KLF5 pathway, providing a diagnostic biomarker for OA.CONCLUSIONCircCDK14 reintroduction assuaged IL-1β-caused chondrocyte damage by the miR-1183/KLF5 pathway, providing a diagnostic biomarker for OA. |
Author | Lai, Xiaowei Tian, Jimei Song, Yali |
Author_xml | – sequence: 1 givenname: Xiaowei surname: Lai fullname: Lai, Xiaowei organization: Department of Rheumatology, Heping Hospital Affiliated to Changzhi Medical College – sequence: 2 givenname: Yali surname: Song fullname: Song, Yali organization: Department of Rheumatology, Heping Hospital Affiliated to Changzhi Medical College – sequence: 3 givenname: Jimei surname: Tian fullname: Tian, Jimei organization: Department of Rheumatology, Heping Hospital Affiliated to Changzhi Medical College |
BookMark | eNqFkc9qFEEQxgeJ4Cb6CMIcvUzSPf0fL8pqNGRBEAVvTU1PTbbjTPfa3UuY1_JBfCZnszEHD3qpguL7flXFd1qdhBiwql5Sck6JJhdEGyoN4-ctadulaKo5e1KtqCSq0bz9dlKtDprmIHpWneZ8SwhpleSrKq59cut315TXMOHoY4KCufahYBpx_92Hhv762fjQ7x32tdvG0Kfo5oJ1DxPcYN3NddliPfnPDaWaXVxvLkW9g7K9g3nh1DEXjJDKNvni8_Pq6QBjxhcP_az6evn-y_pjs_n04Wr9dtM4xkxpFJHKIHYEpWO87wzpGTAhKVcD09Bx0knXakE6LpxkmmkDwhC-PK8p5R07q66O3D7Crd0lP0GabQRv7wcx3djlJu9GtB0z2AsjCAjNUfUGlASFWiqhpBZ0Yb06snYp_thjLnby2eE4QsC4z7aVSitmWioWqThKXYo5JxweV1NiD2HZP2HZQ1j2IazF9_ovn_MFio-hJPDjf91vjm4fhpgmuItp7G2BeYxpSBCcz5b9G_EbB2-tww |
CitedBy_id | crossref_primary_10_1016_j_heliyon_2023_e13152 crossref_primary_10_1007_s00018_024_05460_4 crossref_primary_10_3390_biom13111606 crossref_primary_10_1111_os_13848 crossref_primary_10_3390_ijms232315174 crossref_primary_10_1002_mco2_723 crossref_primary_10_1038_s41598_023_29561_5 crossref_primary_10_1016_j_bcp_2023_115580 crossref_primary_10_3389_fgene_2023_1173812 |
Cites_doi | 10.1080/15384101.2020.1772545 10.1186/gb-2003-4-2-206 10.1042/BSR20201573 10.1002/jcp.27384 10.1038/nsmb.2959 10.1016/j.joca.2016.12.024 10.1038/nrrheum.2011.109 10.1016/j.ymthe.2019.01.006 10.1002/cbin.10761 10.1111/jcmm.14400 10.1016/j.yjmcc.2014.11.023 10.1016/j.prp.2011.09.015 10.1042/BSR20191523 10.1136/annrheumdis-2018-214786 10.1186/ar4133 10.1093/jb/mvaa119 10.2174/1566523219666190716092203 10.1016/j.cell.2009.01.002 10.1016/j.bbrc.2018.11.157 10.1016/j.bbrc.2018.02.036 10.1007/978-981-10-1498-7_7 10.3390/cells7080092 10.5312/wjo.v6.i1.95 10.1001/jama.2018.19319 10.1159/000055915 10.3892/mmr.2016.5419 10.1016/j.bone.2005.08.007 10.1136/annrheumdis-2013-204308 10.1074/jbc.M709857200 10.1016/j.omtn.2020.07.039 10.7150/thno.45993 10.18632/aging.102160 10.1016/S0021-9258(18)61450-4 10.1016/j.intimp.2021.107704 10.1080/21505594.2020.1735051 10.1016/j.bbadis.2019.06.010 10.1016/j.omtn.2019.02.005 |
ContentType | Journal Article |
Copyright | 2022 Informa UK Limited, trading as Taylor & Francis Group 2022 |
Copyright_xml | – notice: 2022 Informa UK Limited, trading as Taylor & Francis Group 2022 |
DBID | AAYXX CITATION 7X8 DOA |
DOI | 10.1080/08916934.2022.2081843 |
DatabaseName | CrossRef MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1607-842X |
EndPage | 417 |
ExternalDocumentID | oai_doaj_org_article_b39ed5950a584e7d9a76a7e867576851 10_1080_08916934_2022_2081843 2081843 |
Genre | Research Article |
GroupedDBID | --- 00X 03L 0BK 0YH 23N 36B 4.4 5GY AALUX AAMIU AAPUL AAQRR ABBKH ABDBF ABEIZ ABJNI ABLIJ ABLKL ABUPF ABXYU ACENM ACGEJ ACGFS ACUHS ADCVX ADRBQ ADXPE AECIN AENEX AEOZL AFKVX AGDLA AGFJD AGRBW AGYJP AIJEM AJWEG AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC AMDAE BABNJ BLEHA BOHLJ CCCUG CS3 DKSSO EAP EBC EBD EBS EMB EMK EMOBN EPL ESX F5P H13 HZ~ KRBQP KSSTO KWAYT KYCEM LJTGL M4Z O9- P2P RNANH RVRKI SV3 TBQAZ TDBHL TERGH TFDNU TFL TFW TUROJ TUS UEQFS V1S ~1N AAGDL AAYXX ABWVI ADYSH AFRVT CITATION 7X8 GROUPED_DOAJ |
ID | FETCH-LOGICAL-c339t-70679eeb0e6c34db90d3a356147f38ab40b6c2850b45c638389a59042088114b3 |
IEDL.DBID | DOA |
ISSN | 0891-6934 1607-842X |
IngestDate | Wed Aug 27 01:28:10 EDT 2025 Fri Jul 11 08:39:35 EDT 2025 Thu Apr 24 22:56:35 EDT 2025 Tue Jul 01 03:37:39 EDT 2025 Wed Dec 25 09:05:50 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c339t-70679eeb0e6c34db90d3a356147f38ab40b6c2850b45c638389a59042088114b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/b39ed5950a584e7d9a76a7e867576851 |
PQID | 2678739215 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | crossref_primary_10_1080_08916934_2022_2081843 crossref_citationtrail_10_1080_08916934_2022_2081843 doaj_primary_oai_doaj_org_article_b39ed5950a584e7d9a76a7e867576851 informaworld_taylorfrancis_310_1080_08916934_2022_2081843 proquest_miscellaneous_2678739215 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-08-18 |
PublicationDateYYYYMMDD | 2022-08-18 |
PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-18 day: 18 |
PublicationDecade | 2020 |
PublicationTitle | Autoimmunity (Chur, Switzerland) |
PublicationYear | 2022 |
Publisher | Taylor & Francis Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
References | CIT0030 CIT0010 CIT0032 CIT0031 CIT0012 CIT0034 CIT0033 CIT0014 CIT0036 CIT0035 CIT0016 CIT0038 CIT0015 CIT0037 CIT0018 CIT0017 CIT0039 CIT0019 Wu Q (CIT0013) 2020; 24 CIT0021 CIT0020 CIT0001 CIT0023 CIT0022 Yuan S (CIT0011) 2019; 39 CIT0003 CIT0025 CIT0002 CIT0024 CIT0005 CIT0027 CIT0004 CIT0026 CIT0007 CIT0029 CIT0006 CIT0028 CIT0009 CIT0008 |
References_xml | – ident: CIT0025 doi: 10.1080/15384101.2020.1772545 – ident: CIT0033 doi: 10.1186/gb-2003-4-2-206 – ident: CIT0031 doi: 10.1042/BSR20201573 – ident: CIT0010 doi: 10.1002/jcp.27384 – ident: CIT0008 doi: 10.1038/nsmb.2959 – ident: CIT0038 doi: 10.1016/j.joca.2016.12.024 – ident: CIT0004 doi: 10.1038/nrrheum.2011.109 – ident: CIT0018 doi: 10.1016/j.ymthe.2019.01.006 – ident: CIT0026 doi: 10.1002/cbin.10761 – ident: CIT0014 doi: 10.1111/jcmm.14400 – ident: CIT0032 doi: 10.1016/j.yjmcc.2014.11.023 – ident: CIT0035 doi: 10.1016/j.prp.2011.09.015 – ident: CIT0020 doi: 10.1042/BSR20191523 – volume: 39 start-page: 1312 year: 2019 ident: CIT0011 publication-title: Nan Fang Yi Ke Da Xue Xue Bao – ident: CIT0017 doi: 10.1136/annrheumdis-2018-214786 – ident: CIT0027 doi: 10.1186/ar4133 – ident: CIT0012 doi: 10.1093/jb/mvaa119 – ident: CIT0005 doi: 10.2174/1566523219666190716092203 – ident: CIT0015 doi: 10.1016/j.cell.2009.01.002 – ident: CIT0030 doi: 10.1016/j.bbrc.2018.11.157 – ident: CIT0006 doi: 10.1016/j.bbrc.2018.02.036 – ident: CIT0007 doi: 10.1007/978-981-10-1498-7_7 – ident: CIT0016 doi: 10.3390/cells7080092 – ident: CIT0024 doi: 10.5312/wjo.v6.i1.95 – ident: CIT0003 doi: 10.1001/jama.2018.19319 – ident: CIT0023 doi: 10.1159/000055915 – ident: CIT0028 doi: 10.3892/mmr.2016.5419 – ident: CIT0001 doi: 10.1016/j.bone.2005.08.007 – ident: CIT0002 doi: 10.1136/annrheumdis-2013-204308 – ident: CIT0034 doi: 10.1074/jbc.M709857200 – ident: CIT0039 doi: 10.1016/j.omtn.2020.07.039 – ident: CIT0029 doi: 10.7150/thno.45993 – ident: CIT0019 doi: 10.18632/aging.102160 – ident: CIT0022 doi: 10.1016/S0021-9258(18)61450-4 – ident: CIT0037 doi: 10.1016/j.intimp.2021.107704 – ident: CIT0021 doi: 10.1080/21505594.2020.1735051 – ident: CIT0036 doi: 10.1016/j.bbadis.2019.06.010 – ident: CIT0009 doi: 10.1016/j.omtn.2019.02.005 – volume: 24 start-page: 7937 issue: 15 year: 2020 ident: CIT0013 publication-title: Eur Rev Med Pharmacol Sci |
SSID | ssj0002764 |
Score | 2.37666 |
Snippet | The pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA cyclin... Background The pathogenesis of osteoarthritis (OA), an endemic and debilitating disease, remains unclear. The study aimed to reveal the role of circular RNA... |
SourceID | doaj proquest crossref informaworld |
SourceType | Open Website Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 408 |
SubjectTerms | circCDK14 exosomes KLF5 miR-1183 |
Title | CircCDK14 ameliorates interleukin-1β-induced chondrocyte damage by the miR-1183/KLF5 pathway in osteoarthritis |
URI | https://www.tandfonline.com/doi/abs/10.1080/08916934.2022.2081843 https://www.proquest.com/docview/2678739215 https://doaj.org/article/b39ed5950a584e7d9a76a7e867576851 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NTttAEF5VoCIuqKRFpBS0lbhuY3u9tvdIQiNESA-oSLmt9s8iInFQ6gjltXgQnokZ_0SUHnLpdeW1VzuzM9_Mer4h5NyBk3PcC2Zd5lgcal8lmpjMHVhDB2ZZY4Hz-FdydRdfT8TkTasv_CespgeuN65nuPROSBFocJU-dVKniU59BkAXkHJVPB2Bz2uDqcYGR2lNHJXJkCWSx23tDrJqwxgOQWwYYSVWhh1P_vJKFXn_O-rSf0x15X-Gn8hBAxzpRb3gQ_LBFx3ysW4lue6QvXFzSf6ZLAbTpR1cjsKY6rmfYQ0-4EmKxBDLmV89TAsWvjwzCMZBrI6C_UPSArsuPXV6DvaFmjUFXEjn01sGkQHvjW6GgmLv4ie9hvdQLAxZwNbdV4xIX8jd8OfvwRVr-iowy7ksWYrJI-9N4BPLY2dk4LjmSAma5jzTJg5MYqNMBCYWFs4nYBotZIAX8RmET4YfkZ1iUfhjQq0MbMRFHkkEXrnRAgJOAA1G-zwHJNIlcbuvyjak49j7YqbClpu0EYdCcahGHF3yYzPtsWbd2Dahj0LbPIyk2dUAqJJqVEltU6UukW9FrsoqZ5LXDU4U37KA761-KDigeOuiC79Y_VERwIEUUGgovv6PRZ6QffwuprXD7BvZKZcrfwq4qDRnZPeif9kfnlVH4RVd6AJW |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CircCDK14+ameliorates+interleukin-1%CE%B2-induced+chondrocyte+damage+by+the+miR-1183%2FKLF5+pathway+in+osteoarthritis&rft.jtitle=Autoimmunity+%28Chur%2C+Switzerland%29&rft.au=Xiaowei+Lai&rft.au=Yali+Song&rft.au=Jimei+Tian&rft.date=2022-08-18&rft.pub=Taylor+%26+Francis+Group&rft.issn=0891-6934&rft.eissn=1607-842X&rft.volume=55&rft.issue=6&rft.spage=408&rft.epage=417&rft_id=info:doi/10.1080%2F08916934.2022.2081843&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_b39ed5950a584e7d9a76a7e867576851 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0891-6934&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0891-6934&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0891-6934&client=summon |